These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Trobe JD, Wall M, Xing D, Optic Neuritis Study Group. Am J Ophthalmol; 2004 Jan; 137(1):77-83. PubMed ID: 14700647 [Abstract] [Full Text] [Related]
23. The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study. Trauzettel-Klosinski S, Diener HC, Dietz K, Zrenner E. Doc Ophthalmol; 2004 Jan; 91(2):165-79. PubMed ID: 8813496 [Abstract] [Full Text] [Related]
24. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin. Shayegannejad V, Shahzamani S, Dehghani A, Dast Borhan Z, Rahimi M, Mirmohammadsadeghi A. Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):797-801. PubMed ID: 25605544 [Abstract] [Full Text] [Related]
25. Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Beck RW, Gal RL. Arch Ophthalmol; 2008 Jul; 126(7):994-5. PubMed ID: 18625951 [No Abstract] [Full Text] [Related]
26. Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up. Sudhalkar A, Khamar M, Khamar B. Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1999-2003. PubMed ID: 25231916 [Abstract] [Full Text] [Related]
27. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica]. Guo ST, Li Z, Jiang LB, Wu RH, Peng JT, Wang JW, Wei WB. Zhonghua Yan Ke Za Zhi; 2019 Mar 11; 55(3):180-185. PubMed ID: 30841684 [Abstract] [Full Text] [Related]
28. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Katz B. Trans Am Ophthalmol Soc; 1995 Mar 11; 93():685-708. PubMed ID: 8719696 [Abstract] [Full Text] [Related]
29. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Sellebjerg F, Nielsen HS, Frederiksen JL, Olesen J. Neurology; 1999 Apr 22; 52(7):1479-84. PubMed ID: 10227638 [Abstract] [Full Text] [Related]
30. [Comparative treatment of acute optic neuritis with "boluses" of intravenous methylprednisolone or oral prednisone]. Alejandro PM, Castañón González JA, Miranda Ruiz R, Edgar Echeverria R, Adriana Montãno M. Gac Med Mex; 1994 Apr 22; 130(4):227-30. PubMed ID: 8964329 [Abstract] [Full Text] [Related]
31. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Keltner JL, Johnson CA, Spurr JO, Beck RW. Am J Ophthalmol; 1999 Nov 22; 128(5):543-53. PubMed ID: 10577521 [Abstract] [Full Text] [Related]
32. The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Volpe NJ. Arch Ophthalmol; 2008 Jul 22; 126(7):996-9. PubMed ID: 18625952 [No Abstract] [Full Text] [Related]
33. The clinical spectrum and prognosis of idiopathic acute optic neuritis: A longitudinal study in Southern Finland. Siuko M, Kivelä TT, Setälä K, Tienari PJ. Mult Scler Relat Disord; 2019 Oct 22; 35():215-220. PubMed ID: 31401426 [Abstract] [Full Text] [Related]
34. Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. Morrow SA, Fraser JA, Day C, Bowman D, Rosehart H, Kremenchutzky M, Nicolle M. JAMA Neurol; 2018 Jun 01; 75(6):690-696. PubMed ID: 29507942 [Abstract] [Full Text] [Related]
35. Design, methods, and conduct of the Optic Neuritis Treatment Trial. Cleary PA, Beck RW, Anderson MM, Kenny DJ, Backlund JY, Gilbert PR. Control Clin Trials; 1993 Apr 01; 14(2):123-42. PubMed ID: 8500302 [Abstract] [Full Text] [Related]
36. A prospective randomized trial of megadose methylprednisolone and high dose dexamethasone for traumatic optic neuropathy. Chuenkongkaew W, Chirapapaisan N. J Med Assoc Thai; 2002 May 01; 85(5):597-603. PubMed ID: 12188391 [Abstract] [Full Text] [Related]
37. [Pulse therapy in the treatment of optic neuritis in multiple sclerosis]. Neroev VV, Karlova IZ, Guseva MR, Zaĭtseva OV, Boĭko SIu, Sidorenko EI, Dubovskaia LA, Budzinskaia MV, Boĭko AN. Vestn Oftalmol; 2003 May 01; 119(5):28-31. PubMed ID: 14598491 [Abstract] [Full Text] [Related]
38. The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group. Long DT, Beck RW, Moke PS, Blair RC, Kip KE, Gal RL, Katz BJ. J Neuroophthalmol; 2001 Jun 01; 21(2):124-31. PubMed ID: 11450903 [Abstract] [Full Text] [Related]
39. Experience of the optic neuritis treatment trial. Corbett J. Curr Neurol Neurosci Rep; 2004 Sep 01; 4(5):383. PubMed ID: 15324604 [No Abstract] [Full Text] [Related]
40. Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a multicenter, double-blind, randomized, controlled phase III study. Mimura O, Ishikawa H, Kezuka T, Shikishima K, Suzuki T, Nakamura M, Chuman H, Inoue K, Kimura A, Yamagami A, Mihoya M, Nakao Y. Jpn J Ophthalmol; 2021 Jan 01; 65(1):122-132. PubMed ID: 33469728 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]